Evidence map›Paper›PMID 32797212›Full record

ArticleJournal of the National Cancer Institute2021

The Association of Veterans' PSA Screening Rates With Changes in USPSTF Recommendations.

Daniel J Becker, Temitope Rude, Dawn Walter, Chan Wang, Stacy Loeb, Huilin Li, Shannon Ciprut, Matthew Kelly, Steven B Zeliadt, Angela Fagerlin and 4 more

Registry-linked trialOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03445559 (A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03445559 naactive not recruitingnot on this map

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2018 to 2027Enrolled58ConditionsProstate CancerArmsClinical Order Check, Academic Detailing, Audit and Feedback
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Daniel J BeckerVA New York Harbor Healthcare System, New York University, New York, NY, USA.
Temitope RudeVA New York Harbor Healthcare System, New York University, New York, NY, USA.
Dawn WalterVA New York Harbor Healthcare System, New York University, New York, NY, USA.
Chan WangDepartment of Population Health, New York University, New York, NY, USA.
Stacy LoebVA New York Harbor Healthcare System, New York University, New York, NY, USA.
Huilin LiDepartment of Population Health, New York University, New York, NY, USA.ORCID 0000-0002-8288-7068
Shannon CiprutVA New York Harbor Healthcare System, New York University, New York, NY, USA.
Matthew KellyVA New York Harbor Healthcare System, New York University, New York, NY, USA.ORCID 0000-0001-6907-310X
Steven B ZeliadtVA Puget Sound Healthcare System and University of Washington, Seattle, WA, USA.
Angela FagerlinDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA.
Herbert LeporPerlmutter Cancer Center, New York University, New York, NY, USA.
Scott ShermanVA New York Harbor Healthcare System, New York University, New York, NY, USA.ORCID 0000-0003-1752-7303
Joseph E RavenellDepartment of Population Health, New York University, New York, NY, USA.
Danil V MakarovVA New York Harbor Healthcare System, New York University, New York, NY, USA.
VA NY Harbor Healthcare System · USNew York University · USUniversity of Utah · USUniversity of Washington · US

Funding

Randomized trial of community health worker-led decision coaching to promote shared decision making for prostate cancer screening among Black male patients and their providersR01MD012243 · NIMHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MAKAROV, DANIL V., RAVENELL, JOSEPH E · 2018 to 2022
$3.9M
NIMHD NIH HHS R01 MD012243
6 · The paper itself

Abstract

backgroundIn 2012, the United States Preventative Services Task Force (USPSTF) formally recommended against all prostate-specific antigen (PSA) screening for prostate cancer. Our goal was to characterize PSA screening trends in the Veterans Health Administration (VA) before and after the USPSTF recommendation and to determine if PSA screening was more likely to be ordered based on a veteran's race or age.

methodsUsing the VA Corporate Data Warehouse, we created 10 annual groups of PSA-eligible men covering 2009-2018. We identified all PSA tests performed in the VA to determine yearly rates of PSA screening. All statistical tests were 2-sided.

resultsThe overall rate of PSA testing in the VA decreased from 63.3% in 2009 to 51.2% in 2018 (P < .001). PSA screening rates varied markedly by age group during our study period, with men aged 70-80 years having the highest initial rate and greatest decline (70.6% in 2009 to 48.4% in 2018, P < .001). Men aged 55-69 years had a smaller decline (65.2% in 2009 to 58.9% in 2018, P < .001) whereas the youngest men, aged 40-54 years, had an increase in PSA screening (26.2% in 2009 to 37.8% in 2018, P < .001).

conclusionsIn this analysis of PSA screening rates among veterans before and after the 2012 USPSTF recommendation against screening, we found that overall PSA screening decreased only modestly, continuing for more than one-half of the men in our study. Veterans of different races had similar screening rates, suggesting that VA care may minimize racial disparities. Veterans of varying ages experienced statistically significantly differences in PSA screening trends.

Indexed as

Prostatic NeoplasmsVeteransAdultAgedAged, 80 and overEarly Detection of CancerHumansMaleMass ScreeningMiddle AgedProstate-Specific AntigenUnited StatesProstate-Specific Antigen

Identifiers

PMID32797212
PMCPMC8096364
OpenAlexW3049211590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.